The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, yeah, there's not a lot of data on this, but certainly, if you have surmised that there is a blood-flow issue and they're having difficulties with orgasm, it's certainly something you can try off-label. And certainly people do try these medications off-label to see if they improve sexual function for women. But there's not a whole bunch of robust, randomized, controlled trial studies on women with these medications.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.